Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Teng Long,1,2,* Zhoutian Yang,1,2,* Huilan Zeng,1,2,* Weijie Wu,1,2 Zhiwen Hu,1,2 Zhenyun Yang,1,2 Dandan Hu,1,2 Zhongguo Zhou,1,2 Minshan Chen,1,2 Yaojun Zhang1,2 1State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Peopl...

Full description

Bibliographic Details
Main Authors: Long T, Yang Z, Zeng H, Wu W, Hu Z, Hu D, Zhou Z, Chen M, Zhang Y
Format: Article
Language:English
Published: Dove Medical Press 2023-10-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
transarterial chemoembolization
hepatic arterial infusion chemotherapy
tyrosine kinase inhibitors
programmed cell death protein -1
combination therapy
hepatocellular carcinoma
Online Access:https://www.dovepress.com/comparable-clinical-outcomes-between-transarterial-chemoembolization-o-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/comparable-clinical-outcomes-between-transarterial-chemoembolization-o-peer-reviewed-fulltext-article-JHC

Similar Items